Structural insights into engineering a T-cell receptor targeting MAGE-A10 with higher affinity and specificity for cancer immunotherapy (vol 10, e004600, 2022)

被引：0

|

作者：

Simister, P. C.

Border, E. C.

Vieira, J. F.

机构：

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷 / 09期

关键词：

D O I：

10.1136/jitc-2022-004600corr1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

收藏

页数：1

相关论文

共 12 条

[11] DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity (vol 10, e004322corr1, 2022)
Muik, A.
Adams, H. C.
Gieseke, F.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
[12] Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway (vol 10, e004113, 2022)
Zhuo, Y.
Li, S.
Hu, W.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (05)